R

Rapport Therapeutics

Develops precision neuromedicines for brain disorders

Director Clinical Contracts

Contract ManagementConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$195k - $215k /yr

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 10 years of experience reviewing and negotiating clinical trial agreements and/or related vendor contracts within a biotechnology, pharmaceutical, or clinical contract research organization environment.
  • Experience making strategic-level decisions for the Contracts function.
  • Experience advising senior leadership on contracting risk and strategy, with demonstrated executive presence.
  • Experience building, leading, and developing a contracts team.
  • Global contract experience, including familiarity with international site contracting and cross-border legal and privacy considerations.
  • Deep familiarity with clinical trial agreement structures and Fair Market Value principles.
  • Working knowledge of Food and Drug Administration regulations and International Council for Harmonisation Good Clinical Practice guidelines as they pertain to clinical contracting.
  • Strong negotiation skills with a track record of driving agreements to execution efficiently.
  • Experience partnering across Legal, Finance, Development, Chemistry, Manufacturing, and Controls, Quality, Biometrics, Bioanalytics, Regulatory, and Clinical Operations.
  • Ability to manage a high volume of contracts simultaneously with strong organization and attention to detail.

Responsibilities

  • Develop, own, and maintain the clinical contract lifecycle strategy, including templates, fallback language, and negotiation playbooks, to standardize the contracting process as the portfolio scales globally.
  • Review and negotiate site Clinical Trial Agreements and Confidentiality Disclosure Agreements.
  • Develop and align contracting strategy with the clinical development plan, shaping negotiation strategy and risk tolerances in line with pipeline stage and new geographies.
  • Lead end-to-end drafting, review, and negotiation of Confidentiality Disclosure Agreements, Master Service Agreements, Material Transfer Agreements, Statements of Work, License Agreements, and Subscription Agreements.
  • Partner with Clinical Operations, outside counsel, Finance, and clinical research organization and vendor teams to design a preferred vendor program and align contract terms with study timelines and budget parameters.
  • Serve as a strategic advisor to Clinical Operations by surfacing contract risk, budget exposure, and portfolio-level trade-offs to inform program decisions.
  • Track contract status, cycle times, and site activation timelines, and proactively identify and resolve bottlenecks.
  • Ensure all agreements comply with applicable regulations, including Food and Drug Administration regulations, International Council for Harmonisation Good Clinical Practice, the General Data Protection Regulation, other privacy regulations, Fair Market Value standards, and company policies.
  • Maintain accurate, audit-ready contract files and documentation to support inspection readiness.
  • Lead technology and process strategy for the Contracts function, including system and tool selection, rollout, integration, artificial intelligence use, governance, and buy-versus-build decisions.
  • Develop and implement the artificial intelligence strategy and roadmap for the Contracts function.
  • Support department headcount planning and organizational structure, and hire, mentor, and develop a growing team of contract professionals.

About the Company

Rapport Therapeutics

Develops precision neuromedicines for brain disorders

Rapport Therapeutics develops precision neuromedicines for neurological disorders. The company focuses on discovering and developing drugs that act only in disease-relevant areas of the brain to reduce symptoms with fewer side effects. Their discovery platform uses region-specific RAPs (Receptor Associated Proteins) to guide drug targeting to specific brain cells or regions, aiming to improve patient benefit. Unlike many peers, Rapport emphasizes selective targeting through RAPs and relies on experienced leadership to drive science and partnerships, with revenue from developing and potentially running clinical trials and related services. The goal is to provide treatments for drug-resistant epilepsies and mood disorders by delivering therapies that are active only where needed in the brain, reducing unwanted effects and improving outcomes.

Company size
51-200
Company stage
IPO
Headquarters
Boston, MA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Rapport Therapeutics

See more jobs